Physicians running Adult Stem Cell (also called Repair Stem Cell) treatment centers and/or treating patients must be licensed, certified and in good-standing with their country’s medical professional regulatory board.

Physicians running stem cell treatment centers and/or treating patients must have at least six months experience treating human patients with Adult Stem Cells also known as Repair Stem Cells (RSC) or experience as a treating physician (in good-standing) at an RSCI approved treatment center.

RSC used for treatments must be either Autologous (a situation in which the donor and recipient are the same person) or from Umbilical Cords.  Non-autologous and non-umbilical cord stem cell treatments must be labeled “Experimental” until a successful clinical trial is completed by the Treatment Center.

Similarly, treatments using intravenous implant of RSC rather than disease specific implants must be labeled “Experimental” until a successful clinical trial is completed by the Treatment Center using the intravenous implant of cells for the specific disease being treated.

Treatment Center and all treating physicians must have never received a negative finding resulting from a regulatory inquiry or governmental action directly relating to issues of patient relations or fraud in the marketplace.

The stem cell supplying laboratory for the Treatment Center must meet the minimum recognized cGMP (current Good Manufacturing Procedure) standards.

Physicians running treatment centers and/or treating patients must meet at least 3 (three) of the following criteria:

• Prior successful RSC clinical trial (prospective or retrospective)
• Published peer reviewed RSC paper
• Grant for RSC research from a governmental unit and/or a nationally recognized charity/disease advocacy organization
• Presented RSC paper to recognized symposiums/congresses
• At least two Honoraria or Doctorates from recognized academic institutions
• RSC producing laboratories providing RSCs for the Treatment Center must have a history of over 100 successful RSC human implants. ("Successful" is defined as having clearly improved the patient's quality of life.)

Finally, Physicians shall keep this credo above all:

First do no harm; and partner with our patients, to the best of our ability, to help them lead healthy lives.

Applicant agrees to the following Accreditation Application stipulations:

1. Applicant agrees to supply current and historic information regarding the treatment center, its principals and its employees, and any other information the RSCI requests relating to the above requirements and/or to the reliability of the business.


2. Applicant agrees to provide full and accurate disclosure of all information requested on the RSCI then-current application.


3. Applicant agrees to promptly respond to all complaints forwarded by the RSCI or a third party and make a good faith effort to resolve all such complaints consistent with good business and medical practices.


4. Applicant agrees to cooperate with the RSCI in attempting to eliminate the underlying cause(s) of serious complaints and/or patterns of complaints.


5. Applicant agrees to adhere to RSCI established standards of advertising and selling, and cooperate with the RSCI in matters relating to these standards.  Applicant agrees to provide upon request, the scientific data/evidence upon which the treating center’s selling claims are based.


6. Applicant agrees to not use the RSCI name, initials or logo unless they receive express written permission from the RSCI and to limit their use to the specific purpose they received permission for.   

ALL INITIAL APPROVALS AND GOOD STANDING STATUS ARE BASED UPON THE SOLE DISCRETION OF THE RSCI AND ITS SCIENTIFIC ADVISORY BOARD (SAB).